BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200628
DTEND;VALUE=DATE:20200703
DTSTAMP:20200430T163909Z
CREATED:20191220T164248Z
LAST-MODIFIED:20200430T163909Z
UID:35676-1593302400-1593734399@globalbiodefense.com
SUMMARY:[CANCELLED] CSTE Annual Conference 2020
DESCRIPTION:For attendees that have already registered for the 2020 Annual Conference and booked hotel accommodations through CSTE’s official housing provider\, Orchid Events\, no action is required on your part. Your meeting registration will automatically be cancelled\, and a full refund will be issued via your original payment method within 30 days.  \nThe Council of State and Territorial Epidemiologists will host the CSTE Annual Conference from June 28 – July 2\, 2020 in Seattle\, Washington. \nThis event is attended by more than 1\,700 public health epidemiologists from across the country and will include workshops\, plenary sessions with leaders in the field of public health\, oral breakout sessions\, roundtable discussions\, and poster presentations. \nConference attendees meet and share their expertise in surveillance and epidemiology as well as best practices in a broad range of areas including informatics\, infectious diseases\, substance use\, immunizations\, environmental health\, occupational health\, chronic disease\, injury control\, and maternal and child health. \nPlease visit the CSTE 2020 website for more information and to register.
URL:https://globalbiodefense.com/event/cste-annual-conference-2020/
LOCATION:Seattle\, Seattle\, WA\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200702
DTEND;VALUE=DATE:20200703
DTSTAMP:20200211T231336Z
CREATED:20200211T230408Z
LAST-MODIFIED:20200211T231336Z
UID:39295-1593648000-1593734399@globalbiodefense.com
SUMMARY:Deadline for NIBIB Technology Accelerator Challenge: Handheld Diagnostics
DESCRIPTION:NIH Technology Accelerator Challenge: Non-invasive Diagnostic Technologies for Global Health \nThis challenge seeks designs for non-invasive technology platforms to diagnose sickle cell disease\, malaria\, and anemia. While not constrained to any specific technology\, the inspiration for this challenge comes from the widespread availability of mobile phones and the potential for mobile phone-linked sensor technologies to non-invasively detect changes in the blood and vasculature associated with these treatable diseases. \nKey Dates\nRelease Date: January 31\, 2020\nEstimated Competition Opening Date: March 2\, 2020\nEstimated Competition Closing Date: July 2\, 2020 \nRead more about this opportunity in Funding News. \n  \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-nibib-technology-accelerator-challenge-handheld-diagnostics/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200702T110000
DTEND;TZID=America/New_York:20200702T123000
DTSTAMP:20200624T194613Z
CREATED:20200624T194613Z
LAST-MODIFIED:20200624T194613Z
UID:46421-1593687600-1593693000@globalbiodefense.com
SUMMARY:The U.S. Chemical Supply Chain: Vulnerabilities Highlighted by COVID-19
DESCRIPTION:The National Academies Board on Chemical Sciences and Technology will convene a webcast meeting on July 2\, 2020 to discuss The U.S. Chemical Supply Chain: Vulnerabilities Highlighted by COVID-19. \nThroughout the COVID-19 pandemic\, the chemical industry in the United States has maintained operating status and continues to be at the forefront of worker safety. Despite these achievements\, the pandemic exposed some of the vulnerabilities in the chemical industry’s supply chain. \nWith an increased demand for chemical products\, such as isopropyl alcohol for the production of hand sanitizer\, the United States has seen firsthand the inflexibility of the supply chain to increase or alter production. The “just-in-time” manufacturing approach that many companies previously adopted to maximize efficiency and lower costs has now presented the industry with production challenges and raises the question of how demand can be met if a disruption to the supply chain occurs. Also of note are the specialty chemical and pharmaceutical industries\, which are increasingly vulnerable as they have outsourced many of their operations overseas. \nIn the event of a global disruption or a localized disruption unique to the point of origin\, the United States risks not being able to obtain the products it critically needs—such as personal protective equipment\, medications\, and medical equipment—as has occurred in the case of COVID-19. \n This webinar\, hosted by the Chemical Sciences Roundtable\, will aim to highlight these two vulnerabilities in the supply chain: the inelasticity of the chemical supply chain and the risks posed by the overseas manufacturing of specialty and pharmaceutical chemicals. \nSpeakers include: \n\nDr. David Bem\, VP of Science and Technology and CTO at PPG Industries\, Inc.\nDr. T. Kevin Swift\, Chief Economist at American Chemistry Council\nDr. Ron Piervincenzi\, CEO of United States Pharmacopeia\n\nA recording of the webinar will be made available after the event. Click here to register for this event.
URL:https://globalbiodefense.com/event/the-u-s-chemical-supply-chain-vulnerabilities-highlighted-by-covid-19/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/chemical-sciences-roundtable-nasem-covid-19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200721T100000
DTEND;TZID=America/New_York:20200721T150000
DTSTAMP:20200709T183244Z
CREATED:20200709T183155Z
LAST-MODIFIED:20200709T183244Z
UID:46618-1595325600-1595343600@globalbiodefense.com
SUMMARY:COVID Complexities: Converging Threats\, Fractured Resources
DESCRIPTION:A virtual meeting of the Bipartisan Commission on Biodefense will be held on July 21\, 2020 to discuss “COVID Complexities: Converging Threats\, Fractured Resources”. \nThe ongoing novel coronavirus 2019 (COVID-19) pandemic has taken the lives of more than 100\,000 Americans and damaged the Nation’s economy. As the country reopens\, the disease threatens the public\, now and into the foreseeable future. Federal support for state\, local\, tribal and territorial preparedness and biosurveillance will be crucial to addressing further spread of COVID-19. The Commission intends to address national policy and resource needs for response to and recovery from this crisis. \nSpeakers include: \nJared Moskowitz – Director\, Florida Division of Emergency Management \nAlexis Madrigal – Co-Founder\, The COVID Tracking Project\, and Staff Writer\, The Atlantic \nDavid Mitchell – President\, International Association of Emergency Medical Services Chiefs \nSpeakers will discuss the potential for compoundment of the biological threat\, disease-tracking needs\, hospital preparedness\, and emergency management challenges. \nPlease visit the Bipartisan Commission on Biodefense website to register for this free event.
URL:https://globalbiodefense.com/event/covid-complexities-converging-threats-fractured-resources/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://globalbiodefense.com/event/covid-complexities-converging-threats-fractured-resources/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200722T140000
DTEND;TZID=America/New_York:20200722T163000
DTSTAMP:20200709T212451Z
CREATED:20200709T212352Z
LAST-MODIFIED:20200709T212451Z
UID:46694-1595426400-1595435400@globalbiodefense.com
SUMMARY:Next Steps for Functional Genomics: A Workshop and Proceedings Release
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine (NASEM) will convene in a virtual meeting open to the public on July 22\, 2020 to unveil and summarize written proceedings a previous workshop on the future of functional genomics research. \nDuring this proceedings release\, you will have the opportunity to hear from Gene Robinson and Lauren O’Connell\, who were members of the workshop planning committee\, about important insights that were gained over the course of the workshop. \nThe workshop itself was held in February in Washington\, DC\, and included speakers\, panels\, and interactive sessions\, that explored the scientific advancements needed to utilize functional genomics to solve societal problems in areas such as conservation\, evolutionary studies\, agriculture\, energy\, defense\, human health\, and other sectors. \nOver the course of the workshop speakers and participants looked to address the current state of the science\, what lessons have been learned thus far\, what current impediments there are to further progress\, and areas where additional investments could help move the field forward. Importantly\, the workshop served as a platform for discussion within the functional genomics community. \nPlease visit the NASEM website to register. \n 
URL:https://globalbiodefense.com/event/next-steps-for-functional-genomics-a-workshop-and-proceedings-release/
CATEGORIES:Conference,Webinar-Webcast,Workshop
LOCATION:https://nasem.zoom.us/webinar/register/WN_HRB5dQrxRaq16gYVKyZnmA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200727
DTEND;VALUE=DATE:20200731
DTSTAMP:20191225T203815Z
CREATED:20191225T203815Z
LAST-MODIFIED:20191225T203815Z
UID:35853-1595808000-1596153599@globalbiodefense.com
SUMMARY:Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens
DESCRIPTION:The FDA and the University of Texas Medical Branch\, Galveston National Laboratory (UTMB) are sponsoring an annual training course 27-30 July 2020 on how to meet good laboratory practice (GLP) requirements in biosafety level (BSL)-4 facilities. \nThe event will be hosted at the National Ebola Training and Education Center in Omaha\, Nebraska. \nThis  course offers a unique opportunity for the regulatory and scientific communities to discuss complex issues in an interactive environment and identify and share best practices for ensuring nonclinical data quality and integrity in BSL-4 facilities. \nPurpose of course\nThe purpose of this unique educational course is to provide a learning environment that: \n\nPromotes collaboration\nProvides tools for conducting clinical studies\nEnhances mutual understanding of clinical\, scientific\, and regulatory complexities\, and\nPromotes the data quality and integrity derived from these regulated studies.\n\nA heightened awareness of the complexities and uniqueness of high- and maximum-containment environments for high-consequence pathogens is the first step in initiating a dialog to find solutions for the planning and execution of studies where data generated will be used to support a regulatory decision. The result is a better-prepared cohesive community of clinical\, scientific\, and regulatory experts mutually engaged in\, and committed to\, the development\, research\, and approval of medical countermeasures for high-consequence pathogens. \nProfessionals who have experience with high-consequence pathogen clinical trials are encouraged to register\, including: \n\nPhysicians\nScientists\nPrincipal investigators\nPhysician assistants\nNurses and nurse practitioners\nPharmacists\nClinical laboratorians\nClinical research staff and clinical monitors\nRegulators and regulatory reviewers\nPolicy-makers\nIRB professionals\nIndustry sponsors\n\nCourse objectives and curriculum\nObjectives\n\nFormulate solutions to regulatory\, operational\, and cultural challenges for the conduct of clinical trials of medical countermeasures for high-consequence pathogens\nIdentify and mitigate risks to data quality and integrity\nResolve complexities of performing clinical trials in biocontainment / barrier nursing environment under good clinical practices (GCPs)\nGain experience conducting clinical research tasks in a mock biocontainment environment while wearing high-level personal protective equipment (PPE)\n\nCourse curriculum\n\nAddressing cultural and language barriers\nEthical considerations for placebo-controlled studies\nRegulatory expectations\nStudy monitoring\nBarrier nursing challenges\nSample integrity\nProtocol development\nOperationalizing a protocol\nProtocol driven data collection vs. clinical data\nGood documentation practices\nReporting adverse events\nInternational issues\nStakeholder roles and responsibilities\n\nBenefits of attending\n\nAttend this free course and earn continuing education (CE) credits.\nLearn from world-renowned faculty members and subject matter experts.\nApply best practices for clinical trials during an outbreak involving high-consequence pathogens.\nRecognize and prevent potential risks to data quality and integrity.\nEnhance cultural awareness and diversity involving clinical trials in geographic locations where outbreaks caused by high-consequence pathogens are frequent.\n\nAttendees will also learn from integrated scenarios\, case studies based on real-life experiences\, and expert panels\, along with lectures from experts from FDA\, the National Institutes of Health\, the NETEC\, and clinical biocontainment units (BCUs). \nPlease visit the FDA website Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens for more information and UTMB’s Registration Page. \n 
URL:https://globalbiodefense.com/event/achieving-data-quality-and-integrity-in-clinical-trials-involving-high-consequence-pathogens/
LOCATION:National Ebola Training and Education Center (NETEC)\, Omaha\, NE\, United States
CATEGORIES:Training
END:VEVENT
END:VCALENDAR